Javier Haurat
YOU?
Author Swipe
View article: Developing a Collaborative Virtual Biobank to Support Infectious Disease Research
Developing a Collaborative Virtual Biobank to Support Infectious Disease Research Open
The COVID-19 pandemic has highlighted the importance of biospecimens in driving new research, disease understanding and the development of diagnostic tests and treatments. Many infectious disease studies collect samples in an isolated mann…
View article: Health map for HealthGap: Defining a geographical catchment to examine cardiovascular risk in Victoria, Australia
Health map for HealthGap: Defining a geographical catchment to examine cardiovascular risk in Victoria, Australia Open
The HealthGap study aimed to understand cardiovascular risk among Indigenous Australians in Victoria using linked administrative data. A key challenge was differing spatial coverages of sources: state-level data for risk factors but cardio…
View article: 39O Four years and 1400+ patient referrals: Achievements of the Australian Rare Cancer Portal
39O Four years and 1400+ patient referrals: Achievements of the Australian Rare Cancer Portal Open
Patients diagnosed with rare cancers (RC, incidence < 6/100,000 person-years) face challenges in accessing RC care and clinical trials. Clinicians are often uncertain how to seek expert guidance. RC trials and research programs have diffic…
View article: The APPRISE Virtual Biobank for Infectious Diseases
The APPRISE Virtual Biobank for Infectious Diseases Open
The Australian Partnership for Preparedness Research on InfectiouS disease Emergencies (APPRISE) has developed a virtual biobank to support infectious disease research in Australia. The virtual biobank (https://apprise.biogrid.org.au) inte…
View article: Tolerability and efficacy of sodium–glucose co‐transporter‐2 inhibitors in Australian Aboriginal and Torres Strait Islanders with type 2 diabetes mellitus: an observational study
Tolerability and efficacy of sodium–glucose co‐transporter‐2 inhibitors in Australian Aboriginal and Torres Strait Islanders with type 2 diabetes mellitus: an observational study Open
Sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) have renal and cardiovascular benefits in addition to their glucose‐lowering potential. Data on the efficacy and safety of SGLT2i in Australian Aboriginal and Torres‐Strait Islanders are …
View article: 1430Guideline-based cardiovascular disease risk assessment among Indigenous Australians in a general practice setting
1430Guideline-based cardiovascular disease risk assessment among Indigenous Australians in a general practice setting Open
Background HealthGap is a population-based cohort study aiming to understand health inequities in cardiovascular disease (CVD) risk between Indigenous and non-Indigenous Australians. We examined guideline-based CVD risk assessment in Victo…
View article: <scp>WhiMSICAL</scp>: A global Waldenström's Macroglobulinemia patient‐derived data registry capturing treatment and quality of life outcomes
<span>WhiMSICAL</span>: A global Waldenström's Macroglobulinemia patient‐derived data registry capturing treatment and quality of life outcomes Open
To the Editor: Waldenström's Macroglobulinemia (WM) is a low-grade non-Hodgkin lymphoma with an incidence of approximately three per million-persons per year,1 classifying it as a rare cancer. Rare cancers are inherently difficult to study…